Teleflex (TFX) Business Metric Overview - Stocknear

Teleflex

NYSE: TFX · Real-Time Price · USD
130.78
1.69 (1.31%)
At close: Sep 05, 2025, 3:59 PM
129.94
-0.64%
After-hours: Sep 05, 2025, 06:10 PM EDT

Teleflex Revenue Breakdown

Period Ending Jun 29, 2025 Mar 30, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Sep 25, 2022 Jun 26, 2022 Mar 27, 2022 Dec 31, 2021 Sep 26, 2021 Jun 27, 2021 Mar 28, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 31, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Sep 25, 2016 Jun 26, 2016 Mar 27, 2016 Dec 31, 2015 Jun 28, 2015 Mar 29, 2015 Dec 31, 2014 Sep 28, 2014 Dec 31, 2011 Sep 25, 2011 Jun 26, 2011
Anesthesia Revenue 96.39M 86.59M 95.29M 101.15M 102.49M 96.35M 98.17M 97.61M 100.84M 93.33M 99.63M 97.61M 104.69M 86.96M 102.78M 97.07M 95.43M 84.86M 86.08M 75.65M 64.87M 75.7M 85.31M 87.12M 85.72M 80.25M 86.17M 87.97M 89.81M 85.42M n/a 99.61M 100.21M 76.85M 60.98M 53.13M 57.92M 53.18M 107.43M 55.69M 55.54M 172.91M 60.2M 600K 219K 234K
Anesthesia Revenue Growth +11.31% -9.12% -5.80% -1.30% +6.37% -1.85% +0.57% -3.20% +8.05% -6.32% +2.07% -6.77% +20.40% -15.40% +5.88% +1.73% +12.46% -1.42% +13.79% +16.62% -14.31% -11.27% -2.08% +1.63% +6.82% -6.87% -2.05% -2.05% +5.14% n/a -100.00% -0.60% +30.40% +26.03% +14.77% -8.27% +8.91% -50.50% +92.90% +0.26% -67.88% +187.22% +9933.33% +173.97% -6.41% n/a
Interventional Urology Revenue 76.39M 70.97M 84.85M 83.39M 83.1M 79.74M 92.97M 73.62M 77.82M 75.38M 89.15M 78.97M 79.82M 74.89M 92.95M 83.11M 92.24M 73.36M 93.96M 81.77M 40.09M 74.19M 89.14M 73.63M 67.95M 59.73M 57.77M 48.99M 47.67M 42.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 138.55M 66M 72.89M
Interventional Urology Revenue Growth +7.64% -16.36% +1.75% +0.35% +4.22% -14.22% +26.27% -5.39% +3.24% -15.45% +12.89% -1.06% +6.57% -19.42% +11.84% -9.90% +25.73% -21.92% +14.90% +103.95% -45.96% -16.76% +21.06% +8.35% +13.76% +3.40% +17.90% +2.77% +12.70% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a +109.94% -9.46% n/a
Interventional Revenue 170.02M 137.56M 160.37M 149.87M 141.16M 134.66M 135.67M 134.09M 124.78M 116.9M 125.08M 108.74M 114.34M 96.86M 114.94M 104.3M 112.08M 96.17M 106.72M 93.19M 82.59M 99.93M 112.71M 106.88M 104.78M 103.18M 167.16M 79.4M 77.18M 71.68M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interventional Revenue Growth +23.60% -14.22% +7.01% +6.17% +4.82% -0.74% +1.18% +7.46% +6.74% -6.54% +15.03% -4.90% +18.05% -15.73% +10.20% -6.94% +16.54% -9.89% +14.53% +12.83% -17.35% -11.34% +5.45% +2.00% +1.55% -38.27% +110.52% +2.88% +7.67% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Revenue 59.85M 53.51M 58.24M 54.76M 41.7M 52.52M 68.26M 76.03M 75.95M 71.65M 73.59M 69.91M 72.14M 69.51M 84.68M 83.38M 86.84M 81.68M 98.08M 86.02M 91.41M 91.74M 89.37M 83.94M 88.4M 85.56M 37.4M 105.84M 111.52M 112.09M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Revenue Growth +11.84% -8.12% +6.35% +31.31% -20.58% -23.07% -10.22% +0.11% +6.00% -2.63% +5.25% -3.08% +3.77% -17.92% +1.57% -3.99% +6.32% -16.72% +14.03% -5.90% -0.35% +2.65% +6.47% -5.05% +3.32% +128.77% -64.66% -5.09% -0.51% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Surgical Revenue 114.04M 105.78M 121.91M 111.75M 111.3M 105.52M 109.58M 112.81M 105.95M 99.02M 110.45M 93.12M 99.64M 89.7M 106.35M 92.83M 98.19M 80.39M 92.27M 82.22M 67.28M 75.43M 95.16M 92.62M 95.57M 86.72M 92.68M 89.91M 90.49M 85.63M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Surgical Revenue Growth +7.81% -13.23% +9.09% +0.40% +5.48% -3.70% -2.86% +6.47% +7.00% -10.35% +18.60% -6.54% +11.08% -15.66% +14.57% -5.45% +22.14% -12.88% +12.22% +22.22% -10.81% -20.73% +2.75% -3.09% +10.21% -6.43% +3.08% -0.64% +5.67% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Vascular Access Revenue 185.53M 182.37M 189.32M 180.9M 181.1M 181.35M 186.69M 169.92M 173.78M 177.65M 186.42M 167.15M 163.91M 166.13M 193.05M 175.48M 167.74M 163.97M 182.44M 160.05M 164.96M 150.26M 154.65M 148.68M 153.65M 143.9M 147.77M 142.71M 140.6M 144.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Vascular Access Revenue Growth +1.73% -3.67% +4.66% -0.12% -0.14% -2.86% +9.87% -2.22% -2.18% -4.71% +11.53% +1.98% -1.34% -13.94% +10.02% +4.61% +2.30% -10.12% +13.99% -2.97% +9.78% -2.84% +4.01% -3.23% +6.78% -2.62% +3.54% +1.50% -2.52% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 29, 2025 Mar 30, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Sep 25, 2022 Jun 26, 2022 Mar 27, 2022 Dec 31, 2021 Sep 26, 2021 Jun 27, 2021 Mar 28, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 31, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Sep 25, 2016 Jun 26, 2016 Mar 27, 2016 Dec 31, 2015 Sep 27, 2015 Jun 28, 2015 Mar 29, 2015 Dec 31, 2014 Sep 28, 2014 Jun 29, 2014 Mar 30, 2014 Dec 31, 2013 Sep 29, 2013 Jun 30, 2013 Mar 31, 2013 Sep 25, 2011 Jun 26, 2011
Americas Segment Revenue 525.64M 475.72M 56.9M 433.33M 426.81M 406.29M 450.62M 428.21M 424.64M 411.86M 457.99M 405.04M 412.74M 377.96M 451.7M 417.33M 414.79M 375.49M 78.61M 68.21M 67.07M 53.13M 27.41M 77.86M 75.23M 60.78M 116.44M 60.41M 60.49M 49.55M 83.88M 72.39M 63.99M 48.95M 72.98M 64.09M 63.19M 49.16M 69.22M 61.94M 62.04M 48.53M 63.52M 62.03M 62.54M 49.6M 212.52M 192.49M 199.7M 195.75M 132.52M 43.82M
Americas Segment Revenue Growth +10.49% +736.03% -86.87% +1.53% +5.05% -9.84% +5.23% +0.84% +3.10% -10.07% +13.07% -1.87% +9.20% -16.32% +8.24% +0.61% +10.46% +377.70% +15.23% +1.71% +26.24% +93.84% -64.80% +3.50% +23.78% -47.80% +92.73% -0.12% +22.06% -40.92% +15.88% +13.13% +30.71% -32.92% +13.88% +1.42% +28.55% -28.99% +11.76% -0.17% +27.85% -23.60% +2.39% -0.81% +26.08% -76.66% +10.40% -3.61% +2.02% +47.71% +202.40% n/a
Asia Revenue 89.03M 73.79M 248.15M 98.26M 87M 84.21M 88.34M 93.15M 86.68M 78.73M 78.5M 82.03M 76.61M 69.19M 78.52M 74.96M 80.6M 63.69M 161.44M 135.65M 131.64M 156.12M 209.96M 140.52M 147.05M 154.54M 103.12M 160.5M 168.88M 171.32M 158.51M 131.52M 131.96M 130.73M 135.74M 121.4M 131.71M 122.09M 135.18M 120.85M 129.13M 129.28M 147M 141.15M 154.67M 150.25M 59.17M 55.26M 50.41M 42.37M n/a 143.56M
Asia Revenue Growth +20.65% -70.27% +152.54% +12.95% +3.31% -4.68% -5.16% +7.47% +10.09% +0.30% -4.30% +7.07% +10.72% -11.88% +4.75% -7.01% +26.56% -60.55% +19.02% +3.04% -15.68% -25.64% +49.42% -4.44% -4.85% +49.87% -35.75% -4.96% -1.42% +8.08% +20.52% -0.34% +0.94% -3.69% +11.81% -7.83% +7.87% -9.68% +11.85% -6.41% -0.12% -12.06% +4.15% -8.74% +2.95% +153.93% +7.06% +9.63% +18.98% n/a n/a n/a
Emea Revenue 166.23M 151.16M 622.89M 150.22M 147.06M 159.66M 152.37M 142.72M 147.81M 143.34M 147.84M 128.44M 145.19M 136.91M 164.54M 143.88M 157.13M 141.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 144.9M 132.26M 137.84M 142.42M n/a n/a
Emea Revenue Growth +9.97% -75.73% +314.64% +2.15% -7.89% +4.78% +6.76% -3.44% +3.12% -3.04% +15.11% -11.54% +6.05% -16.80% +14.36% -8.43% +11.24% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a +9.55% -4.05% -3.21% n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 29, 2025 Mar 30, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Sep 25, 2022 Jun 26, 2022 Mar 27, 2022 Dec 31, 2021 Sep 26, 2021 Jun 27, 2021 Mar 28, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 31, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Sep 25, 2016 Jun 26, 2016 Mar 27, 2016 Dec 31, 2015 Sep 27, 2015 Jun 28, 2015 Mar 29, 2015
Selling, General, and Administrative Revenue 215.08M 222.71M 254.55M 247.26M 250.63M 242.83M 260.65M 213.19M 223.31M 232.72M 233.38M 208.62M 216.93M 203.93M 227.58M 205.19M 224.16M 203.15M 232.91M 171.67M 191.19M 147.8M 240.6M 229.9M 236.19M 227.69M 218.54M 214.89M 229.92M 215.34M 213.29M 163.77M 158.93M 163.97M 144.18M 139.8M 142.98M 136.35M 148.22M 138.84M 142.23M 139.7M
Selling, General, and Administrative Revenue Growth -3.43% -12.51% +2.95% -1.35% +3.21% -6.84% +22.26% -4.53% -4.04% -0.28% +11.87% -3.83% +6.37% -10.39% +10.91% -8.46% +10.34% -12.78% +35.67% -10.21% +29.36% -38.57% +4.66% -2.66% +3.73% +4.19% +1.70% -6.53% +6.77% +0.96% +30.24% +3.04% -3.07% +13.73% +3.14% -2.23% +4.87% -8.01% +6.75% -2.38% +1.81% n/a
Research and Development Revenue 38.52M 36.4M 44.55M 38.73M 41.09M 37.3M 35.86M 37.58M 39.45M 41.47M 42.76M 37.77M 36.93M 36.36M 35.8M 31.82M 33.28M 29.95M 33.77M 29.22M 29.36M 27.4M 31.13M 27.98M 27.59M 27.15M 27.8M 26.36M 26.02M 26.03M 25.47M 21.19M 20.28M 17.83M 15.69M 15.07M 15.47M 12.35M 13.22M 12.57M 13.44M 12.88M
Research and Development Revenue Growth +5.82% -18.29% +15.05% -5.76% +10.17% +4.02% -4.57% -4.75% -4.87% -3.01% +13.20% +2.26% +1.58% +1.58% +12.51% -4.41% +11.14% -11.32% +15.58% -0.50% +7.18% -11.99% +11.23% +1.41% +1.64% -2.33% +5.44% +1.33% -0.03% +2.18% +20.18% +4.52% +13.75% +13.64% +4.11% -2.62% +25.25% -6.57% +5.17% -6.49% +4.34% n/a